Physician profile
Akshay Garg
NPI 1518223411
$17,701.51
in general payments reported to CMS, 2019-2025
22 companies · $906 in 2025
The $906 reported for 2025 was more than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
See the full distribution for Pain Medicine (Physical Medicine & Rehabilitation)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,587 · 2020: $1,189 · 2021: $2,732 · 2022: $1,860 · 2023: $1,322 · 2024: $1,106 · 2025: $906.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,334.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,333.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biodelivery Sciences International, INC. | $8,193.37 | 2019-2021 | |
| Abbott Laboratories | $4,771.47 | 2019-2025 | Proclaim, Eterna, Octrode |
| Medtronic, INC. | $1,494.83 | 2022-2025 | Intellis Adaptivestim, Inceptiv, Vanta Adaptivestim |
| Medtronic USA, INC. | $995.02 | 2019 | |
| Boston Scientific Corporation | $975.44 | 2019-2025 | Wavewriter Alpha Prime 16 |
| Painteq LLC | $220.82 | 2021-2024 | Painteq |
| Nevro Corp. | $187.43 | 2022-2024 | Senza |
| Biotronik Nro, INC. | $157.46 | 2024-2025 | Prospera |
| Scilex Pharmaceuticals INC. | $139.60 | 2019 | |
| Spr Therapeutics, INC | $133.33 | 2019 | |
| Si-Bone, INC. | $122.03 | 2023 | |
| Bioness INC | $118.27 | 2020 | |
| Globus Medical, INC. | $37.50 | 2025 | Xlif |
| Averitas Pharma INC. | $31.20 | 2025 | Qutenza |
| Takeda Pharmaceuticals U.S.A., INC. | $26.28 | 2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $19.59 | 2021 | |
| Fidia Pharma USA INC. | $14.77 | 2022 | |
| Avanos Medical | $13.94 | 2024 | Standard Rf Disposables |
| Horizon Therapeutics Plc | $12.39 | 2019 | |
| Collegium Pharmaceutical, INC. | $12.36 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $12.23 | 2019 | |
| Kaleo, INC. | $12.18 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Akshay Garg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.